3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
10
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
3
Glioblastoma
3
Colorectal Neoplasms
3
Skin Neoplasms
2
Ovarian Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Hot Flashes
2
Vulvodynia
1
Thromboembolism
1
Severe Acute Respiratory Syndrome
1
Recurrence
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Hemorrhage
1
Pleural Effusion, Malignant
1
Platinum Resistant Ovarian Cancer
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Pain, Postoperative
1
Neutropenia
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Interventions
fludarabine phosphate
22
Mycophenolic Acid
17
Whole-Body Irradiation
15
Peripheral Blood Stem Cell Transplantation
13
Cyclophosphamide
12
Cyclosporine
11
Tacrolimus
10
Cyclosporins
9
Antilymphocyte Serum
9
Busulfan
8
fludarabine
7
Rituximab
7
Sirolimus
5
Methotrexate
5
Melphalan
4
Filgrastim
3
Cytarabine
3
Cord Blood Stem Cell Transplantation
3
thymoglobulin
2
pegfilgrastim
2
ibrutinib
2
Thiotepa
2
Oxaliplatin
2
Granulocyte Colony-Stimulating Factor
2
Etoposide
2
Darbepoetin alfa
2
Clofarabine
2
selinexor
1
sargramostim
1
ofatumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Prolymphocytic
×
Sodium Chloride
×
Clear all
No trials found.